Inventor · disambiguated record
Nike Beaubier
Also filed as: BEAUBIER NIKE · BEAUBIER NIKE T · BEAUBIER NIKE TSIAPERA
10 granted patents·9 pending applications·89 citations·filing 2019–2025
88Inventor score
Top patents by PatentIndex Score
19 records- 0196US11145416B1Predicting likelihood and site of metastasis from patient recordsTEMPUS LABS INC·Filed 2021·Granted Oct 12, 2021·29 cites·80 claims
- 0295US11848107B2Predicting likelihood and site of metastasis from patient recordsTEMPUS LABS INC·Filed 2021·Granted Dec 19, 2023·5 cites·29 claims
- 0395US11244763B2Predicting likelihood and site of metastasis from patient recordsTEMPUS LABS INC·Filed 2021·Granted Feb 8, 2022·5 cites·76 claims
- 0494US12112839B2Data based cancer research and treatment systems and methodsTEMPUS AI INC·Filed 2023·Granted Oct 8, 2024·6 cites·20 claims
- 0592US11705226B2Data based cancer research and treatment systems and methodsTempus Labs·Filed 2019·Granted Jul 18, 2023·24 cites·86 claims
- 0690US11527323B2Systems and methods for multi-label cancer classificationTEMPUS LABS INC·Filed 2020·Granted Dec 13, 2022·15 cites·8 claims
- 0783US11640859B2Data based cancer research and treatment systems and methodsTempus Labs·Filed 2019·Granted May 2, 2023·5 cites·83 claims
- 0883US2024312581A1Data based cancer research and treatment systems and methodsTEMPUS AI INC·Filed 2024·Application pending·0 cites
- 0975US2025364135A1Systems and methods for multi-label cancer classificationTEMPUS AI INC·Filed 2024·Application pending·0 cites
- 1071US11651442B2Mobile supplementation, extraction, and analysis of health recordsTEMPUS LABS INC·Filed 2022·Granted May 16, 2023·0 cites·30 claims
- 1169US2022335306A1Techniques for resolving discordant her2 status in pathology images for diagnosing breast cancerTEMPUS LABS INC·Filed 2022·Application pending·0 cites
- 1268US11367004B2Real-world evidence of diagnostic testing and treatment patterns in U.S. breast cancer patients with implications for treatment biomarkers from RNA-sequencing dataTEMPUS LABS INC·Filed 2020·Granted Jun 21, 2022·0 cites·29 claims
- 1368US2022351805A1Systems and methods for detecting cellular pathway dysregulation in cancer specimensTEMPUS LABS INC·Filed 2022·Application pending·0 cites
- 1466US2021248479A1Real-World Evidence of Diagnostic Testing and Treatment Patterns in U.S. Breast Cancer Patients with Implications for Treatment Biomarkers from RNA-Sequencing DataTEMPUS LABS INC·Filed 2021·Application pending·0 cites
- 1565US2023187070A1Systems and methods for multi-label cancer classificationTEMPUS LABS INC·Filed 2022·Application pending·0 cites
- 1664US2025279214A1Cancer treatment efficacy evaluation upon undergoing or completing a cancer treatmentTEMPUS AI INC·Filed 2025·Application pending·0 cites
- 1763US11367508B2Systems and methods for detecting cellular pathway dysregulation in cancer specimensTEMPUS LABS INC·Filed 2020·Granted Jun 21, 2022·0 cites·35 claims
- 1863US2023245788A1Data based cancer research and treatment systems and methodsTEMPUS LABS INC·Filed 2023·Application pending·0 cites
- 1962US2021142904A1Systems and methods for multi-label cancer classificationTEMPUS LABS INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nike Beaubier files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →